Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/transave-receives--242-2-million-cystic-fibrosis-foundation-award-for-development-of-arikace-28tm-29-4650-1/;/a><br) was not found.

Search medicine technology 1 transave receives 242 2 million cystic fibrosis foundation award for development of arikace 28tm 29 4650 1 ; a><br at Google

Search medicine technology 1 transave receives 242 2 million cystic fibrosis foundation award for development of arikace 28tm 29 4650 1 ; a><br at Yahoo

Search medicine technology 1 transave receives 242 2 million cystic fibrosis foundation award for development of arikace 28tm 29 4650 1 ; a><br at Msn

Google
 
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
(Date:12/13/2009)... 2009Researchers at The Scripps Research Institute have solved ... from an ancient family of enzymes can have ... addition to providing guidance for understanding other molecules ... underpinning for the protein,s possible use for combating ... research was published in the December 13, 2009 ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 1Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 2Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 3LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 1LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 2LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 3LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 4LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 5Thoratec Presentation at Baird Conference to be Webcast 13764 1
(Date:12/15/2009)... Massage, and Medical tables announces its partnership with Contour Table ... to ease pressure felt while laying face down during massage. ... ... December 15, 2009 -- OAKWORKS®, Inc., the premier U.S. manufacturer ... of the Utopian Massage Table with patent pending ABC System, ...
(Date:12/15/2009)... the Dec. 15 issue of the Journal of ... obese increases the risk for developing obstructive sleep apnea ... , Results indicate that the risk of OSA ... increased 3.5 fold with each standard-deviation increase in body ... did not significantly increase with increasing BMI among younger ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... Dec. 14 Heska Corporation (Nasdaq: ... a leading provider of veterinary diagnostic and ... installation of the Company,s new DRI-CHEM® 7000 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving ... multi-patient clinical chemistry analyzer available to the ...
(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... automates the denaturation and hybridization steps in ... for clinical and research personnel. The low ... sample types, is easy to use, and ... while ensuring overall precision and accuracy in ...
Extremely high efficiency packaging extracts useful for transfecting our EpiFOS™ or CopyControl™ Fosmids, or any DNA vector with cos sites. A tremendous value when conpared to the competition...
... Iodide (PI) is a fluorescent nucleic acid ... acids. As a nuclear counterstain, propidium ... red in color. The fluorescent red ... blue fluorochromes such as FITC, Cy2 or ...
Biology Products:
... tests for Nystagmus when rotated at ... by 8" diameter. Light weight drum ... for effortless spin mechanism. For use ... Includes both Adult and Pediatric Drums ...
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
... This Illuminated Stand Magnifier offers versatility ... Both the lens and the light ... and small hand held objects can ... the lens parallel to the work ...
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products:
(Date:12/14/2009)... Colo. and THOUSAND OAKS, Calif., Dec. 14 /PRNewswire-FirstCall/ ... and Amgen Inc.(Nasdaq: AMGN ) today announced ... exclusive worldwide rights to Array,s small-molecule glucokinase activator ... Phase 1 clinical trial in patients with Type ... of the agreement, Array will receive an upfront ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... Dec. 14 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, owing to ... fibrillation drug market will increase more than sevenfold ... in 2018 in the United States, France, Germany, ... The new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/11/2009)... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: ... of its previously announced public offering have exercised ... 2,250,000 shares of common stock at the public ... exercise of the option increases the size of ... of common stock. Dendreon expects to receive ...
Breaking Biology Technology:Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
(Date:12/14/2009)... a statement by Linda A. Suydam, D.P.A., president ... today,s release of the National Institute on Drug ... released today on this year,s Monitoring the Future ... to educate and empower parents with the information ... medicine abuse. The Consumer Healthcare Products Association (CHPA) ...
(Date:12/14/2009)... -- Corgenix Medical Corporation (OTC Bulletin Board: ... diagnostic test kits, and BG Medicine, Inc. ... announced today a supply agreement whereby Corgenix ... enzyme-linked immunosorbent assay (ELISA) microtiter format exclusively ... regulatory clearance in the United States of ...
(Date:12/14/2009)... Associates, a leading public affairs agency providing ... issues management, today announced that it has ... PSID ) to serve as the ... Associates will conduct media relations for PositiveID,s ... its public relations programs. ,, PositiveID, headquartered ...
Breaking Medicine Technology:Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Blood Thinner May Prevent Chemo Related Clots 55837 1Blood Thinner May Prevent Chemo Related Clots 55837 2Health Plan Executives to Share Winning Strategies in the Age of Reform During Health Integrated Forum 55832 1Health Plan Executives to Share Winning Strategies in the Age of Reform During Health Integrated Forum 55832 2Aflac Announces Support for Childhood Cancer Awareness Month 55827 1Aflac Announces Support for Childhood Cancer Awareness Month 55827 2Aflac Announces Support for Childhood Cancer Awareness Month 55827 3Aflac Announces Support for Childhood Cancer Awareness Month 55827 4Aflac Announces Support for Childhood Cancer Awareness Month 55827 5